Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer

Clinical trial NCT03384914 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03384914
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Female Breast Cancer, Male Breast Cancer Stage I Breast Cancer Stage II Breast Cancer Stage III Residual Disease HER2-positive Breast Cancer HER2 Positive Breast Carcinoma

Start date: 2018-02-19
Primary completion: 2025-12-22
Enrollment: 119

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.